American Cancer Society
Edit

American Cancer Society

https://www.cancer.org/
Last activity: 30.10.2024
Active
Categories: EdTechInformationLearnNonprofitResearchService
For cancer information, call 1-800-227-2345 anytime, day or night, or visit www.cancer.org
Website visits
7.1M /mo.
Mentions
893
Location: United States, Atlanta
Employees: 5001-10000
Phone: +1 800-227-2345
Total raised: $11.58M
Founded date: 1913

Funding Rounds 3

DateSeriesAmountInvestors
27.07.2022-$83K-
09.02.2021Grant$5M-
05.10.2018-$6.5M-

Mentions in press and media 893

DateTitleDescription
30.10.2024Actor and Social Media Influencer Nathaniel Buzolic (Nate Buzz) Launches New Faith Podcast "Against the Grain"David Latting and Nathaniel Buzolic for Against the Grain On October 29, 2024, Hollywood actor and social media influencer Nathaniel Buzolic, launched Against the Grain, a new podcast series where faith meets culture in candid conversations...
29.10.2024Regional and Global Experts Convene in Accra, Ghana to Update Cancer Treatment Guidelines for Sub-Saharan AfricaOngoing international oncology collaboration works to empower health care workers and save lives across diverse resource environments. Accra, GHANA, Oct. 29, 2024 /PRNewswire/ -- International oncology experts are gathering in Accra, Ghana ...
18.10.2024Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancerIf approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible for adjuvant treatment with Kisqali® (ribociclib) in combinati...
16.10.2024Clarity Pharmaceuticals' AMPLIFY Trial: A New Dawn for Prostate Cancer DiagnosticsIn the world of prostate cancer diagnostics, hope often flickers like a candle in the dark. Clarity Pharmaceuticals is about to turn that flicker into a beacon. The company recently received a green light from the U.S. Food and Drug Adminis...
16.10.2024Copper-67 SAR-bisPSMA updatesSYDNEY, Oct. 16, 2024 /PRNewswire/ -- HIGHLIGHTS Cohort 4 - SECuRE Trial The third participant of cohort 4 (multi-dose) of the SECuRE trial1 has now completed the Dose Limiting Toxicity (DLT) period after a second dose of 12GBq of 67Cu-SAR-...
15.10.2024Perficient Receives Two Sitecore Experience AwardsPerficient, the leading global digital consultancy transforming the world’s largest enterprises and biggest brands, announced that it has received the 2024 Sitecore Partner Experience Award for Global Practice Excellence. Sitecore also reco...
14.10.2024Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancerHighlights United States Food and Drug Administration (U.S. FDA) provided positive feedback on a pivotal Phase III trial for 64Cu-SAR-bisPSMA diagnostic in prostate cancer patients with biochemical recurrence (BCR), AMPLIFY. The positive re...
08.10.2024New Frontiers in Lung Cancer Detection and Treatment: A Dual ApproachLung cancer remains a formidable adversary in the battle against cancer. It is the leading cause of cancer-related deaths globally. However, recent advancements in detection and treatment offer a glimmer of hope. Two significant development...
08.10.2024Bridging the Gap: The Crucial Role of Pharmacogenomics in Mental Health TreatmentIn the realm of mental health, the quest for effective treatment often resembles a game of chance. Patients shuffle through a deck of medications, hoping to find the right fit. The stakes are high. Lives hang in the balance. Yet, a powerful...
08.10.2024MediLink Announces Global Clinical Trial Collaboration and Supply Agreement on YL201 Combination TherapySUZHOU, China, Oct. 8, 2024 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announced a global clinical trial collaboration and supply agreement with Amgen Inc. Amgen ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In